Nektar Therapeutics Eulerpool News

Nektar Therapeutics Eulerpool News

Nektar Therapeutics Stock News

Nektar Therapeutics is being monitored by journalists and investors worldwide. We gather the latest Nektar Therapeutics news here.

• November 1 ·

  GuruFocus
  Nektar Therapeutics (NKTR) Stock Surges Amidst Mixed Financials
• October 31 ·

  Yahoo
  Nektar to Announce Financial Results for the Third Quarter 2024 on Thursday, November 7, 2024, After Close of U.S.-Based Financial Markets
• October 29 ·

  Yahoo
  Nektar Announces Publication in Nature Communications of Results from Phase 1b Studies of Rezpegaldesleukin in Two Inflammatory Skin Diseases
• October 29 ·

  TipRanks
  Nektar’s rezpegaldesleukin Phase 1 study featured in peer-reviewed publication
• October 29 ·

  Thefly.com
  Nektar's rezpegaldesleukin Phase 1 study featured in peer-reviewed publication
• October 28 ·

  GuruFocus
  Nektar Therapeutics (NKTR) Shares Surge Amidst Moderate Biotech Sector Gains
• October 17 ·

  Yahoo
  Nektar Announces Publication in Blood of Phase 1 Data for Novel IL-15 Agonist NKTR-255 in Combination with Autologous CD19-22 CAR-T Cell Therapy in Patients with B-cell Acute Lymphoblastic Leukemia
• October 17 ·

  Thefly.com
  Nektar says published Phase 1 NKTR-25 data show favorable efficacy
• October 17 ·

  Seeking Alpha
  Nektar sees promising phase 1 results of NKTR-255 in B-cell lymphoblastic leukemia
• October 4 ·

  GuruFocus
  Nektar Therapeutics (NKTR) Stock Surges Amid Market Fluctuations